Wikidata

(Q65470757)

English

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

clinical trial

In more languages

Statements

title
A Randomized, Double-Blind Phase 3 Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine Plus Placebo For The First-Line Treatment Of Patients With Locally Advanced, Unresectable Or Metastatic Pancreatic Cancer. (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
France
0 references
Germany
0 references
Hungary
0 references
India
0 references
Republic of Ireland
0 references
Italy
0 references
Japan
0 references
Netherlands
0 references
Singapore
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Taiwan
0 references
United Kingdom
0 references
start time
July 2007
0 references
end time
January 2009
0 references
number of participants
630
0 references
research site
Pfizer
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65470757&oldid=1913647905"